Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 361.40
+2.90 (0.81%)
At close: Apr 21, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 585.04 billion as of April 21, 2026. Its market cap has increased by 41.47% in one year.
Market Cap
585.04B
Enterprise Value
751.88B
Revenue
168.27B
Ranking
n/a
PE Ratio
96.83
Stock Price
361.40
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 585.04B, an increase of 1,188.27%. That is a compound annual growth rate of 12.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 585.04B | 11.30% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 33.33B |
| Titan Biotech | 19.39B |
| Hester Biosciences | 12.57B |
| CCME Global | 3.86B |
| Zenotech Laboratories | 2.90B |
| Bharat Immunologicals & Biologicals Corporation | 760.40M |
| Transgene Biotek | 234.13M |
| Hindustan Bio Sciences | 96.56M |